Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry

Abstract Background and purpose The use of direct oral anticoagulants (DOAC) has increased sharply and DOAC are the oral anticoagulant therapy (OAT) of choice for the majority of patients with newly-diagnosed atrial fibrillation. Intracranial hemorrhage is the most severe adverse event of OAT. Syste...

全面介紹

書目詳細資料

發表在:	Neurological Research and Practice
Main Authors:	Waltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, Barbara Zydek, Simone Lindau, Stavros Konstantinides, Oliver Grottke, Ulrike Nowak-Göttl, Christian von Heymann, Ingvild Birschmann, Jan Beyer-Westendorf, Patrick Meybohm, Andreas Greinacher, Eva Herrmann, the RADOA-Registry Investigators (Reversal Agent use in patients treated with Direct Oral Anticoagulants or vitamin K antagonists Registry)
格式:	Article
語言:	英语
出版:	BMC 2022-05-01
在線閱讀:	https://doi.org/10.1186/s42466-022-00183-y